These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12367656)

  • 1. Multicenter evaluation of the Bayer VERSANT HIV-1 RNA 3.0 assay: analytical and clinical performance.
    Gleaves CA; Welle J; Campbell M; Elbeik T; Ng V; Taylor PE; Kuramoto K; Aceituno S; Lewalski E; Joppa B; Sawyer L; Schaper C; McNairn D; Quinn T
    J Clin Virol; 2002 Aug; 25(2):205-16. PubMed ID: 12367656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of the Cobas Amplicor HIV-1 Monitor Ultrasensitive Test, the new Cobas AmpliPrep/Cobas Amplicor HIV-1 Monitor Ultrasensitive Test and the Versant HIV RNA 3.0 assays for quantitation of HIV-1 RNA in plasma samples.
    Berger A; Scherzed L; Stürmer M; Preiser W; Doerr HW; Rabenau HF
    J Clin Virol; 2005 May; 33(1):43-51. PubMed ID: 15797364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter comparison of Roche COBAS AMPLICOR MONITOR version 1.5, Organon Teknika NucliSens QT with Extractor, and Bayer Quantiplex version 3.0 for quantification of human immunodeficiency virus type 1 RNA in plasma.
    Murphy DG; Côté L; Fauvel M; René P; Vincelette J
    J Clin Microbiol; 2000 Nov; 38(11):4034-41. PubMed ID: 11060065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive comparison of the VERSANT HIV-1 RNA 3.0 (bDNA) and COBAS AMPLICOR HIV-1 MONITOR 1.5 assays on 1,000 clinical specimens.
    Galli R; Merrick L; Friesenhahn M; Ziermann R
    J Clin Virol; 2005 Dec; 34(4):245-52. PubMed ID: 16286047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter evaluation of the performance characteristics of the bayer VERSANT HCV RNA 3.0 assay (bDNA).
    Elbeik T; Surtihadi J; Destree M; Gorlin J; Holodniy M; Jortani SA; Kuramoto K; Ng V; Valdes R; Valsamakis A; Terrault NA
    J Clin Microbiol; 2004 Feb; 42(2):563-9. PubMed ID: 14766817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance characteristics of the QUANTIPLEX HIV-1 RNA 3.0 assay for detection and quantitation of human immunodeficiency virus type 1 RNA in plasma.
    Erice A; Brambilla D; Bremer J; Jackson JB; Kokka R; Yen-Lieberman B; Coombs RW
    J Clin Microbiol; 2000 Aug; 38(8):2837-45. PubMed ID: 10921936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A sensitive branched DNA HIV-1 signal amplification viral load assay with single day turnaround.
    Baumeister MA; Zhang N; Beas H; Brooks JR; Canchola JA; Cosenza C; Kleshik F; Rampersad V; Surtihadi J; Battersby TR
    PLoS One; 2012; 7(3):e33295. PubMed ID: 22479381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative and cost comparison of ultrasensitive human immunodeficiency virus type 1 RNA viral load assays: Bayer bDNA quantiplex versions 3.0 and 2.0 and Roche PCR Amplicor monitor version 1.5.
    Elbeik T; Charlebois E; Nassos P; Kahn J; Hecht FM; Yajko D; Ng V; Hadley K
    J Clin Microbiol; 2000 Mar; 38(3):1113-20. PubMed ID: 10699005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of HIV-1 viral load assays on subtype quantification: Bayer Versant HIV-1 RNA 3.0 versus Roche Amplicor HIV-1 Monitor version 1.5.
    Elbeik T; Alvord WG; Trichavaroj R; de Souza M; Dewar R; Brown A; Chernoff D; Michael NL; Nassos P; Hadley K; Ng VL
    J Acquir Immune Defic Syndr; 2002 Apr; 29(4):330-9. PubMed ID: 11917236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter evaluation of the NucliSens EasyQ HIV-1 v1.1 assay for the quantitative detection of HIV-1 RNA in plasma.
    de Mendoza C; Koppelman M; Montès B; Ferre V; Soriano V; Cuypers H; Segondy M; Oosterlaken T
    J Virol Methods; 2005 Jul; 127(1):54-9. PubMed ID: 15893566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The significance of HIV viral load assay precision: a review of the package insert specifications of two commercial kits.
    Chernoff DN
    J Int Assoc Physicians AIDS Care (Chic); 2002; 1(4):134-40. PubMed ID: 12942672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the clinical sensitivity for the quantification of human immunodeficiency virus type 1 RNA in plasma: Comparison of the new COBAS TaqMan HIV-1 with three current HIV-RNA assays--LCx HIV RNA quantitative, VERSANT HIV-1 RNA 3.0 (bDNA) and COBAS AMPLICOR HIV-1 Monitor v1.5.
    Katsoulidou A; Petrodaskalaki M; Sypsa V; Papachristou E; Anastassopoulou CG; Gargalianos P; Karafoulidou A; Lazanas M; Kordossis T; Andoniadou A; Hatzakis A
    J Virol Methods; 2006 Feb; 131(2):168-74. PubMed ID: 16194575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitation of human immunodeficiency virus type 1 (HIV-1) RNA in cell-free cervicovaginal secretions: comparison of reverse transcription-PCR amplification (AMPLICOR HIV-A MONITOR 1.5) with enhanced-sensitivity branched-DNA assay (Quantiplex 3.0).
    Si-Mohamed A; Andreoletti L; Colombet I; Carreno MP; Lopez G; Chatelier G; Kazatchkine MD; Belec L
    J Clin Microbiol; 2001 Jun; 39(6):2055-9. PubMed ID: 11376034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of the QUANTIPLEX HIV-1 RNA 2.0 and 3.0 (bDNA) assays and the AMPLICOR HIV-1 MONITOR v1.5 test for the quantitation of human immunodeficiency virus type 1 RNA in plasma.
    Anastassopoulou CG; Touloumi G; Katsoulidou A; Hatzitheodorou H; Pappa M; Paraskevis D; Lazanas M; Gargalianos P; Hatzakis A
    J Virol Methods; 2001 Jan; 91(1):67-74. PubMed ID: 11164487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of performance across the dynamic range of the Abbott RealTime HIV-1 assay as compared to VERSANT HIV-1 RNA 3.0 and AMPLICOR HIV-1 MONITOR v1.5 using serial dilutions of 39 group M and O viruses.
    Swanson P; Huang S; Abravaya K; de Mendoza C; Soriano V; Devare SG; Hackett J
    J Virol Methods; 2007 Apr; 141(1):49-57. PubMed ID: 17184853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of a transcription-mediated-amplification HIV-1 RNA assay in pooled specimens.
    Zetola NM; Mintie A; Liska S; Wong E; Williams JD; Busch MP; Klausner JD
    J Clin Virol; 2007 Sep; 40(1):68-70. PubMed ID: 17662648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of three commercial assays for the quantification of HIV-1 RNA in plasma from individuals infected with different HIV-1 subtypes.
    Chew CB; Herring BL; Zheng F; Browne C; Saksena NK; Cunningham AL; Dwyer DE
    J Clin Virol; 1999 Oct; 14(2):87-94. PubMed ID: 10588451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical comparison of an enhanced-sensitivity branched-DNA assay and reverse transcription-PCR for quantitation of human immunodeficiency virus type 1 RNA in plasma.
    Nolte FS; Boysza J; Thurmond C; Clark WS; Lennox JL
    J Clin Microbiol; 1998 Mar; 36(3):716-20. PubMed ID: 9508301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early diagnosis of paediatric HIV-1 infection among African breast-fed children using a quantitative plasma HIV RNA assay.
    Rouet F; Montcho C; Rouzioux C; Leroy V; Msellati P; Kottan JB; You B; Viho I; Dabis F;
    AIDS; 2001 Sep; 15(14):1849-56. PubMed ID: 11579248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discordance between viral loads determined by Roche COBAS AMPLICOR human immunodeficiency virus type 1 monitor (version 1.5) Standard and ultrasensitive assays caused by freezing patient plasma in centrifuged becton-dickinson vacutainer brand plasma preparation tubes.
    Salimnia H; Moore EC; Crane LR; Macarthur RD; Fairfax MR
    J Clin Microbiol; 2005 Sep; 43(9):4635-9. PubMed ID: 16145119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.